Cancer - Fujifilm Pharmacetuicals U.S.A., Inc.

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT03440450

A Phase 1 Dose-escalation Study of FF-10832 for the Treatment of Advanced Solid Tumors

Drug

FF-10832

Condition

confirmed cholangiocarcinoma or gall bladder carcinoma that is metastatic or unresectable